Studying CBD
No Result
View All Result
  • Home
  • CBD
  • About CBD
  • What is CBD
  • Home
  • CBD
  • About CBD
  • What is CBD
No Result
View All Result
Studying CBD
No Result
View All Result
Home CBD

Neptune Technologies & Bioresources Inc (NASDAQ:NEPT), Internationa Flavors & Fragrances, Inc. (NYSE:IFF) – Neptune Wellness Looks To Co-Develop CBD Products With International Flavors & Fragrances

Peter F. by Peter F.
October 2, 2019
in CBD
37 3
0
Neptune Technologies & Bioresources Inc (NASDAQ:NEPT), Internationa Flavors & Fragrances, Inc. (NYSE:IFF) – Neptune Wellness Looks To Co-Develop CBD Products With International Flavors & Fragrances
32
SHARES
360
VIEWS
Share on TwitterShare on Facebook

[ad_1]

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced Wednesday it’s pursuing a partnership with International Flavors & Fragrances Inc. (NYSE: IFF) to co-develop hemp-derived CBD products.

Neptune Wellness Solutions is a company that extracts, purifies and formulate health and wellness products. Its wholly-owned subsidiary 9354-7537 Québec Inc. possesses a Health Canada license for processing cannabis.

See Also: Canopy Growth Enters Sports Nutrition Space, Acquires Majority Stake in BioSteel Sports Nutrition

“IFF is a well-recognized leader and innovator in taste, scent, nutrition and ingredients and we could not be more excited at the potential of combining the resources of our two organizations to develop plant-based consumer products, including hemp-derived CBD products,” said Michael Cammarata, CEO of Neptune.

“The formulation and technological expertise that IFF cumulates will greatly benefit Neptune in accelerating its market penetration in the U.S. CBD market. This partnership aligns well with our growth strategy of expanding core customers and of supporting consumer packaged goods companies and fragrance houses’ expansion into the CBD market.”

Neptune’s stock traded higher by 8.9% to $3.90 per share in Wednesday’s pre-market session.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Source link

RELATED  Ex-Pat Rob Gronkowski's new game plan: Connects with CBD co. - The Villager
Tweet8Share13Share3Share
Peter F.

Peter F.

We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."

No Result
View All Result
  • Privacy Policy
  • Contact
  • About us

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.. For more information contact Info@sdmediagrp.comContinuePrivacy policy